Additional Effects of Scapular Stabilization Exercise With Exergaming Training in Stroke Patients

NCT ID: NCT05673733

Last Updated: 2023-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-10

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The World Health Organization has termed stroke to be a clinical syndrome, of presumed vascular origin, typified by rapidly developing signs of focal or global disturbance of cerebral functions and the leading cause of death worldwide in 2016 making it a major non-contagious cause of death. This study would be beneficial in a way that it will give a valuable input and will contribute for the knowledge of interventions for stroke with an emphasis on upper extremity function among health care practitioners for their goal of promoting health, prevention of diseases and improving quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Exergaming can contribute to improvement of the function of UE motor and AROM in chronic stroke patients, additional studies with a large number of subjects with long follow-up periods are required to determine their effectiveness neurorehabilitation stimulation . The exergaming protocol presented in this study represents success a tool for UE functional aspects in patients with chronic stroke. It has shown improvement in gripping strength, handicrafts and UE's operational recovery. Movement control and the position of scapula determine an optimal upper limb function. Paresis leading to scapular disorientation ultimately exaggerates motor impairment in upper extremities. Recent literature has emphasized on the need to design an upper extremity protocol including scapular stabilization exercises in order to increase muscular strength and decrease scapular dyskinesis .The results of a study showed that scapular stability exercises had an impact on hand function and the ability to move hemiplegic patients after stroke.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Exergaming Training
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Exergaming training combined with Scapular stabilization exercises will be performed for 6 weeks for 3 times per week.

Group Type EXPERIMENTAL

scapular stabilization exercises with exergaming training

Intervention Type OTHER

Group A will receive scapular stabilization exercises with exergaming training

Group B

Exergaming training will be performed for 6 weeks for 3 times per week.

Group Type ACTIVE_COMPARATOR

exergaming training

Intervention Type OTHER

Group B will receive only exergaming training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

scapular stabilization exercises with exergaming training

Group A will receive scapular stabilization exercises with exergaming training

Intervention Type OTHER

exergaming training

Group B will receive only exergaming training

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic Stroke patients with an initial onset of 6 months or above.
* Those who had 30-65 points by Fugl-Meyer Assessment of upper extremity
* Those who had minimum score 24 on mini mental state examination
* Those who have the ability to execute at least 20' of active shoulder flexion and abduction against gravity those who could understand and follow instructions provided by the investigator
* Those who are medically stable enough to participate in active rehab
* Those who have no problems with auditory or visual functioning.
* Modified Ashworth Scale (MAS) 1-3

Exclusion Criteria

* Orthopaedic or mental health problems
* Those who have difficulty to stay in a sitting position
* Severe conditions such as uncontrolled blood pressure or angina
* History of epilepsy
* The refusal to play a video game.
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Misbah Ghous, MSNMPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shumaila

Rawalpindi, , Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Misbah Ghous, MSNMPT

Role: CONTACT

03345695456

Shumaila Kiran, MS*

Role: CONTACT

0334 8842139

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shumaila Kiran, MSNMPT*

Role: primary

03348842139

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Shumailakiran

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.